News
AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...
China's Huawei Technologies is capable of producing no more than 200,000 advanced artificial intelligence chips in 2025, a ...
ADAM SEGAL is Ira A. Lipman Chair in Emerging Technologies and National Security and Director of the Digital and Cyberspace ...
Oak Ridge's uranium enrichment facility supports America's AI ambitions amid concerns that China's aggressive nuclear reactor ...
AI chatbots from Tencent, ByteDance, and Moonshot AI disabled features like photo recognition and real-time question ...
Creating guardrails for AI can't wait, says Jake Sullivan, and the responsibility may ultimately fall on the shoulders of CEOs.
Explore more
U.S. export controls on Nvidia have incentivized China to develop alternatives, while also making it more difficult for ...
Nvidia CEO Jensen Huang announced several AI infrastructure partnerships throughout Europe at GTC Paris on Wednesday ...
In the largest single foreign investment in US history, Taiwan Semiconductor Manufacturing Company (TSMC), the world’s “most ...
Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.
British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC ...
This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results